Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 error instead of the study record. Its footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error screen instead of the usual study-record content, with a Home button indicating restricted access rather than an update to the study data.SummaryDifference20%

- Check52 days agoChange DetectedNIH grant/contract identifiers for 2017 and 2023 were added to the study record. The page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision has been bumped from v3.6.4 to v3.6.5, indicating a new version of the page. The update appears to be a metadata/versioning change rather than a substantive change to the study details or UI.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a new revision of the page. This update does not reflect substantive changes to the study details visible to users.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.